Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches
- Cancer Discov. 2025 Feb 7;15(2):346-362. doi: 10.1158/2159-8290.CD-23-1480.
Affiliations
- 1. Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- 2. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- 3. Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- 4. Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina.
- 5. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- 6. Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- 7. Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Munich, Germany.
- 8. Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California.
- 9. German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
- 10. Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany.
- 11. Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- # Contributed equally.
PMID: 39632628
DOI: 10.1158/2159-8290.CD-23-1480
Abstract
We provide a comprehensive tumor-intrinsic kinome landscape that provides a roadmap for the use of kinase inhibitors in PDAC treatment approaches.